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OBJECTIVES The purpose of this research was to study long-term left ventricular (LV) adaptations in
very-high-level endurance athletes.
BACKGROUND Knowledge of cardiac changes in athletes, who are at particularly high risk of sudden cardiac
death, is mandatory to detect hypertrophic cardiomyopathy (HCM) or dilated (DCM)
cardiomyopathy.
METHODS We carried out echocardiographic examinations on 286 cyclists (group A) and 52 matched
sedentary volunteers (group C); 148 cyclists participated in the 1995 “Tour de France” race
(group A1), 138 in the 1998 race (group A2), and 37 in both (group B).
RESULTS In groups A, A1, A2, and C, respectively, diastolic left ventricular diameter (LVID) was 60.1
 3.9 mm, 59.2  3.8 mm, 61.0  3.9 mm, and 49.0  4.3 mm (A vs. C and A1 vs. A2,
p  0.0001), and maximal wall thickness (WT) was 11.1  1.3 mm, 11.6  1.3 mm, 10.6
 1.1 mm, and 8.6  1.0 mm (A vs. C and A1 vs. A2, p  0.0001). Among group A, 147
(51.4%) had LVID 60 mm; 17 of them had also a below normal (52%) left ventricular
ejection fraction (LVEF). Wall thickness exceeded 13 mm in 25 athletes (8.7%) (always 15
mm), 23 with LVID 55 mm. In group B, LVID increased (58.3  4.8 mm to 60.3  4.2
mm, p  0.001) and WT decreased (11.8  1.2 mm to 10.8  1.2 mm, p  0.001) with
time.
CONCLUSIONS Over one-half of these athletes exhibited unusual LV dilation, along with a reduced LVEF
in 11.6% (17 of 147), compatible with the diagnosis of DCM. Increased WT was less
common (always 15 mm) and scarce without LV dilation (1%), eliminating the diagnosis
of HCM. Serial examinations showed evidence of further LV dilation along with wall
thinning. These results might have important implications for screening in athletes. (J Am
Coll Cardiol 2004;44:144–9) © 2004 by the American College of Cardiology Foundationw
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athlete’s heart is characterized by a physiologic increase in
eft ventricular (LV) wall thickness (WT) and mass, to-
ether with cavity dilation in the case of endurance activities
1). Professional cyclists demonstrate the largest increase in
oth cavity size and WT due to a combination of extreme
olume and pressure overload (2). Although such modifi-
ations are well known, reports on large homogeneous
roups of highly trained athletes, who are particularly at risk
f sudden cardiac death, are scarce. Furthermore, no long-
erm studies on LV morphology and function are available.
See page 150
owever, such data might help us to detect cardiac diseases.
oreover, the performances of professional cyclists have
onsiderably improved in recent years. In the Tour de
rance, the mean speed increased from 36 km/h in 1985 to
0 km/h in 1998, and the mean workload developed by the
From the *Service de Cardiologie, †Unite´ d’E´pide´miologie et de Recherche
linique, and §Centre d’Investigations Cliniques, Hoˆpital Europe´en Georges Pom-
idou, Paris, France; and ‡Institut Cœur Effort Sante´, Paris, France.
Manuscript received November 18, 2003; revised manuscript received January 24,P004, accepted February 17, 2004.inner reached 370 W in 1991 compared with 445 W in
995. It is also likely that many performance enhancers were
sed during this period (3,4). As a part of the systematic
edical follow-up, which is mandatory in France, we
erformed echocardiographic examinations on the partici-
ants in the 1995 and 1998 Tour de France races.
ETHODS
tudy population. Professional cyclists (group A) partici-
ating in the 1995 (group A1) or 1998 (group A2) Tour de
rance or both (group B) underwent a screening echocar-
iogram. In 1995, 148 of the 198 participants agreed to be
xamined, and in 1998, 138 of the 198 agreed. All exami-
ations were performed during the two days preceding the
ace by the same investigator (E.A.) using a Sonos 2500
ewlett Packard echograph machine (Philips, Andover,
assachusetts) equipped with a 2.5-MHz probe. Thirty-
even athletes (group B) who participated in both races were
xamined twice. A control group of 52 young male physi-
ians (group C) matched for body surface area (BSA) was
lso evaluated between September 1995 and February 1996.
art of echographic data (mean LV diameter and mass)
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ublished (5).
easurements. For each subject, at least three two-
imensional-guided M-mode recordings of the LV were
ecorded on videotapes. Paper tracings were obtained simul-
aneously. All recordings were performed as recommended
y Devereux et al. (6) and by the American Society of
chocardiography (7). Readings were taken after all record-
ngs had been completed, and LV measurements were
veraged over three cardiac cycles. The parameters recorded
ncluded left ventricular internal diameters at end-diastole
LVIDd) and left ventricular internal diameters at end-
Table 1. Main Characteristics of the Study Po
Cyclists Controls
n 286 52
Age (yrs) 28.4  3.2 26.3  4.0
Weight (kg) 71.0  6.4 71.0  8.8
Height (cm) 179  6 177  6
BSA (m2) 1.89  0.11 1.87  0.14
HR (beats/min) 51.8  8.6 70.7  13.4
LVIDd (mm)
(range)
60.1  3.9
(49–73)
49.0  4.3
(41–60)
LVIDdi (mm/m2) 31.9  2.2 26.2  2.2
LVIDs (mm) 39.7  4.1 31.4  4.1
IVSTd (mm) (range) 11.1  1.3
(8.7–14.8)
8.6  1.0
(7.0–10.7)
PWTd (mm) (range) 10.0  1.0
(6.5–13.8)
8.0  0.9
(6.5–11.2)
LVMi (g/m2)
(range)
141  21
(84–222)
73  11
(50–99)
RWT 0.354 0.342
LVEF (%) (range) 61.6  6.4
(41–77)
65.3  6.7
(52–77)
eFS (%) 33.9  4.6 36.1  5.0
mFS (%) 17.3  1.9 18.5  2.0
CO (l/mn) 5.7  1.3 5.2  1.3
CI (l/mn/m2) 3.0  0.7 2.7  0.6
ESS (103 dynes/cm2) 63.7  15.5 58.4  13.2
*Cyclists versus controls; †1995 cyclists versus 1998 cyclists.
BSA  body surface area; CI  cardiac index; CO 
meridional end-systolic stress; HR  heart rate; IVSTd
ventricular ejection fraction; LVIDd  left ventricular inte
ventricular internal diameter; LVIDs  left ventricular intern
mFS  midwall fractional shortening; PWTd  end-diasto
Abbreviations and Acronyms
BSA  body surface area
DCM  dilated cardiomyopathy
eFS  endocardial fractional shortening
ESS  meridional end-systolic stress
HCM  hypertrophic cardiomyopathy
LV  left ventricle/ventricular
LVEF  left ventricular ejection fraction
LVH  left ventricular hypertrophy
LVIDd left ventricular internal diameter at end-diastole
LVIDs  left ventricular internal diameters at end-systole
mFS  midwall fractional shortening
WT  wall thicknessthickness.ystole (LVIDs), end-diastolic interventricular septal wall
hickness (IVSTd), and posterior wall thickness (PWTd).
ll readings were taken from anonymous tracings by a
ingle investigator (E.A.). The Devereux-modified Ameri-
an Society of Echocardiography-cube formula was used to
alculate LV mass (6) as: 0.8 [1.04 (LVIDd  PWTd 
VSTd)3  LVIDd3]  0.6 g, which was expressed as a
unction of BSA (indexed left ventricular mass, g/m2).
elative WT was calculated as (IVSTd  PWTd)/LVIDd,
ith a distinction between eccentric (relative WT 0.44)
nd concentric (relative WT 0.44) patterns. Left ventric-
lar volumes were calculated using the Teichholz formulas
7/(2.4  LVID)  LVID3] and were used to calculate left
entricular ejection fraction (LVEF, %); cardiac output and
ndex were derived from LVEF and heart rate. Endocardial
ractional shortening (eFS) and midwall fractional shorten-
ng (mFS) were calculated as previously described (8).
nd-systolic meridional stress (ESS) was calculated as
(0.334  SBP  LVIDs)/(PWTs  [1  (PWTs/
VIDs]) (9), where SBP is the systolic blood pressure and
WTs is the systolic posterior WT.
Left ventricular hypertrophy (LVH) was defined as
VSTd and/or PWTd 13 mm and abnormal cavity
ilation as LVIDd 60 mm (10,11). Thresholds corre-
ponding to mean  1.96 SD of data obtained in the
ontrol group were also used to define LV dilation (LVIDd
ion
p*
Cyclists
1995
Cyclists
1998 p†
111 101
0.0001 28.5  3.4 28.1  3.2 0.46
0.93 71.6  6.6 70.2  6.2 0.11
0.07 179  6 179  6 0.77
0.37 1.89  0.12 1.88  0.11 0.35
0.0001 51.7  8.0 51.2  9.2 0.67
0.0001 59.4  3.3
(51–68)
61.2  3.8
(49–73)
0.0003
0.0001 31.5  2.0 32.7  2.4 0.0001
0.0001 38.5  3.2 41.6  4.3 0.0001
0.0001 11.5  1.3
(8.7–14.8)
10.5  1.0
(8.8–13.2)
0.0001
0.0001 10.2  1.2
(6.5–13.8)
9.8  0.7
(8.0–12.5)
0.0018
0.0001 143  22
(88–192)
138  17
(84–177)
0.08
0.06 0.37  0.04 0.33  0.04 0.0001
0.0002 63.6  5.3
(50–75)
59.1  6.8
(41–77)
0.0001
0.0016 35.3  4.0 32.1  4.8 0.0001
0.0001 17.4  1.9 17.2  2.0 0.14
0.009 5.8  1.1 5.7  1.5 0.73
0.007 3.0  0.6 3.0  0.7 0.85
0.02 55.2  10.9 75.0  13.6 0.0001
output; eFS  endocardial fractional shortening; ESS 
-diastolic interventricular septal thickness; LVEF  left
iameter at end-diastole; LVIDdi  indexed diastolic left
eter at end-systole; LVMi  indexed left ventricular mass;
sterior wall thickness at end-systole; RWT  relative wallpulat
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LV Adaptations in World-Class Professional Cyclists July 7, 2004:144–957.4 mm or LVIDd30.6 mm/m2), low LVEF (52%),
nd low mFS (14.5%). To take into account afterload, we
sed the relationship between LVEF and ESS in the control
roup and in the athletes. Using each model, we calculated
he lower limit of the 95% confidence interval of a predicted
VEF for each individual ESS (12). The difference between
his last value and the measured value was used to classify
ubjects: athletes with difference 0 were considered as
aving abnormally low LVEF.
tatistical analysis. Statistical analysis was performed with
he StatView software (Version 4.5, SAS, Inc., Cary, North
arolina). Results are presented as means  1 SD. Differ-
nces between two groups were compared by an unpaired t
est, and differences between more than two groups were
ested by one-way analysis of variance. The paired t test was
sed to assess change within a group. For paired compari-
ons, the Bonferroni correction was used to take into
ccount multiple comparisons. Differences were considered
o be statistically significant if p  0.05.
ESULTS
he main characteristics of the study groups are presented
n Table 1. There were no differences in height, weight, and
SA between the 286 athletes and the 52 control subjects.
ystolic blood pressure (120  9 mm Hg vs. 126  13 mm
g, p  0.0001) and diastolic blood pressure (68  9 mm
g vs. 77 10 mm Hg, p 0.0001) were lower in athletes
igure 1. Plot of left ventricular ejection fraction (LVEF) against left ventricu
pen circles  1998). The solid vertical bar represents the normality thres
hreshold (52%) for LVEF. Numbers in italics in front of each axis value arehan in controls, as was heart rate. aV morphology. Wall thickness and cavity dimensions
ere greater in athletes than in controls (Table 1); LVIDd
as correlated with BSA (r  0.37, p  0.0001) but not
ith age (r  0.002, p  0.98) or heart rate (r  0.015,
 0.80). Left ventricular internal diameter at end diastole
xceeded the upper limit of normal (57.4 mm) in 214
thletes (75%), with values above 60 mm in 147 cases (51%
s. 0% in controls) and above 70 mm in four cases (Fig. 1).
aximal WT exceeded 13 mm in 25 cyclists (8.7% vs. 0%
n controls, always 15 mm), 23 of whom had an LVIDd
55 mm (Fig. 2). The LV geometry was eccentric in 273
thletes and concentric in 13. In all athletes but one, LV
orphology was symmetrical (relative WT 1.5), although
0 athletes had a relative WT 1.3.
V function. The LVEF was 60% in 111 athletes,
etween 40% and 52% in 20 athletes, and between 52% and
6% in 38 athletes (Fig. 1). Although cardiac output and
ardiac index were higher in athletes than in controls,
ndexes of endocardial and midwall LV function (LVEF,
FS, mFS) were all significantly lower in athletes (Table 1).
oreover, LVEF was lower in the 147 cyclists with LV
ilation (60 mm) than in the remaining 139 cyclists (60.5
6.9% vs. 62.8  5.6%, p  0.0027). Conversely, among
he cyclists with abnormal LV dilation, 67 of 147 (46%) had
n LVEF 60%, vs. 39 of 139 (28%) of those with normal
V size (p  0.0021). The mFS was abnormally low in 26
yclists (22 with eccentric LVH) who showed lower LVEF
51.5  4.9% vs. 62.6  5.6% for the remaining 260
ternal diameter at end diastole (LVIDd) in all cyclists (solid circles  1995;
60 mm) for LVIDd, and the solid horizontal bar represents the normality
lative numbers of cyclists with a value below the corresponding axis value.lar in
hold (
cumuthletes, p  0.0001). Finally, 17 athletes (14 in 1998, 3 in
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52%) (Fig. 1). Ten of these athletes had also a low mFS
14.5%). Comparisons between measured LVEF and
redicted LVEF (lower limit of the 95% confidence inter-
al) are shown in Figure 3. All the controls are above the
ero line: measured LVEF values are always higher than
redicted LVEF values. In the subgroup of 17 cyclists with
oth LVIDd 60 mm and LVEF 52%, 7 cyclists are
elow or at the zero line, which means that they might be
igure 2. Plot of left ventricular internal diameter at end diastole (LVIDd
epresents the LVIDd threshold for dilated left ventricle (LV) (55 mm), an
m). Numbers in italics in front of the X axis values are cumulative num
igure 3. Plot between the measured left ventricular ejection fraction (LVE
he 95% confidence interval of the predicted LVEF for a given end systolic
n controls (LVEF  87.55  0.38 · ESS, r  0.75, p  0.0001). (Right)
0.29 · ESS, r  0.71, p  0.0001). Results are shown for the 17 cyclists
52% (solid circles), the remaining cyclists (n  269) (), and the control grlassified as abnormal. Moreover, three cyclists with LVEF
52% and an LVIDd between 58 mm and 60 mm also have
ower than predicted LVEF values.
omparison between 1995 and 1998. Cyclists who took
art in the 1998 race had a larger LV cavity and thinner
alls than those who participated in the 1995 race (Table
). Thus, those who raced in 1998 had a more eccentric
V geometry. In 1995, one cyclist had an LVIDd 70
m compared with three cyclists in 1998 (one cyclist
nst maximal wall thickness (WT) in all cyclists. The solid horizontal bar
solid vertical bar represents the normality threshold for maximal WT (13
of cyclists with a value below the corresponding axis value.
axis) and the difference between measured LVEF and the lower limit of
(ESS) (Y axis). (Left) Predicted LVEF was defined by the model obtained
cted LVEF was defined by the model obtained in cyclists (LVEF  80.34
both left ventricular internal diameter at end diastole 60 mm and LVEF) agai
d theF) (X
stress
Predi
withoup (n  52) (open squares).
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LV Adaptations in World-Class Professional Cyclists July 7, 2004:144–9ook part in both races). A similar pattern was observed
n athletes who participated in both races (group B)
Table 2).
ISCUSSION
chocardiographic screening is mandatory in highly trained
thletes to detect a dilated (DCM) or hypertrophic (HCM)
ardiomyopathy. In our study, based on a large and homo-
eneous cohort of professional bicyclists participating in the
our de France races in 1995 and 1998, most athletes (51%)
isplayed a substantial LV enlargement, 11.6% with indexes
f depressed myocardial performance. Moreover, unex-
ected changes in echocardiographic LV morphology were
bserved between the two races.
V structure evaluation. Endurance cycling has the great-
st impact on LV cavity dimension and WT, due to a
ombination of endurance training (cycling) and isometric
xercise (with the arms). Thus, while LV enlargement
xceeding 60 mm (13) is unusual in non-elite athletes, this
s observed in about 14% of elite athletes (11). We report
ere the largest proportion ever published of athletes with
ubstantial LV enlargement (51% 60 mm, up to 73 mm).
he major determinants of dilation are usually BSA, as is
he case here, and participation in “high-impact” sports such
s cycling, cross-country skiing, canoeing, rowing, and
occer. However, unlike in a previous study (11), consider-
ble LV dilation persisted here after correction for BSA.
ven in the group of 62 athletes with BSA 1.8 m2, 22
35%) exhibited abnormal LV dilation (Table 3). Increased
V WT was less common (9% of the athletes) and similar
o that previously reported (14). It never exceeded 15 mm
nd rarely occurred in the absence of cavity dilation (1%),
llowing easy elimination of the diagnosis of HCM (Fig. 2)
15).
bnormal systolic performance. Although global LV sys-
olic function was within the normal range for the whole
opulation, half of the cyclists with abnormal dilation had
VEF below 60%, and 17 of the 21 athletes with an
bnormally low LVEF (52%) showed an increased LV
able 2. Echocardiographic Characteristics of the Subgroup of
7 Cyclists That Participated in Both the 1995 and 1998 Races
1995 1998 p Value
VIDd (mm) 58.3  4.8 60.3  4.2 0.001
SA (m2) 1.89  0.11 1.89  0.11 0.16
VIDdi (mm/m2) 30.9  2.4 32.0  1.8 0.0011
VIDs (mm) 37.8  4.2 40.3  3.9 0.0001
VSTd (mm) 11.8  1.2 10.8  1.2 0.0002
WTd (mm) 10.6  1.0 9.9  0.8 0.0014
VMi (g/m2) 144  23 138  21 0.05
WT 0.39  0.05 0.35  0.03 0.0001
VEF (%) 63.5  6.3 60.8  5.7 0.01
FS 35.2  4.7 33.3  4.1 0.019
FS 17.0  2.0 17.4  1.9 0.32
bbreviations as in Table 1.ize (60 mm). In a previous study (11), athletes with LV pilation showed a normal global systolic function. More-
ver, in a small group of 21 less trained elite cyclists (16), as
emonstrated by a lower mean LV mass (200 g vs. 266 g in
ur study), LVH was not associated with significant abnor-
alities of cardiac function. It has been suggested that
educed fractional shortening in runners (who show pre-
ominant LV dilation) could be due to a decreased preload
long with a normal afterload and contractile state (17). It
as also been shown that 39% of football players have a
oderately reduced resting LVEF (50% to 55%), which
ppropriately increases with exercise (mean, 76%) (18). In
he present study, whatever the approach used to define
bnormal LV function (association of LV dilation and low
VEF or low afterload-corrected LVEF) (Fig. 3), a de-
ressed myocardial function can be suggested in a small
roup of cyclists (17). It is unlikely that these subjects had a
re-existing DCM, as this condition is very scarce in the
eneral population (36 of 100,000) (19,20). The potential
ole of exercise-induced tachycardia can be excluded, as all
yclists carefully monitored their heart rate during training
nd the races, with a similar average exercise heart rate
around 80% of their maximal heart rate to avoid muscular
xhaustion). It is also possible that illicit drugs might induce
V function deterioration. This factor has not yet been
tudied in detail, even though there is evidence that some
rugs are becoming more popular among athletes (3).
ecent works do not mention potential drug abuse (2), or
liminated this possibility on the questionable basis that
thletes denied the use of illicit drugs (11,21). Moreover,
he combined effects of multiple drugs remain unknown.
erial cardiac changes. Successive examinations in 1995
nd 1998 in the subgroup of 37 cyclists evaluated twice
howed further LV dilation along with wall thinning with
ime. This was not associated with a decrease in cyclist
erformances (Indurain won the 1995 Tour de France—
,635 km—at a mean speed of 39 km/h, whereas Pantani
on the 1998 Tour de France—3,711 km—at a mean speed
f 40 km/h). In 1998, LV diameters were markedly in-
reased, with the largest dimension ever reported in athletes
73 mm). The 2-mm difference in diameter observed
etween 1995 and 1998 in this cohort is of the magnitude
bserved between athletes practicing isotonic and isometric
ports (2). It seems unlikely that this difference was due to
able 3. Comparison of LVIDd in a Subset of Athletes
ngaged in High Impact Sports (Cycling, Cross-Country
kiing, Canoeing, Rowing, and Soccer) (10) and in Professional
yclists (Current Study) According to BSA
BSA Pellicia et al. (10) Current Study
1.8 m2 54.6  3.5 58.1  3.9
n  52 n  62
.81–2 m2 56.3  3.6 60.1  3.6
n  179 n  178
2 m2 59.0  3.2 62.6  3.6
n  86 n  46
SA body surface area; LVIDd left ventricular internal diameter at end-diastole.oor reproducibility of these anonymous readings. In a
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July 7, 2004:144–9 LV Adaptations in World-Class Professional Cyclistsrevious study involving 96 cyclists, the mean interobserver
r intraobserver difference for LV diameters was 0.3 mm
22). A second bias could be due to seasonal changes in LV
orphology: WT is lower during the resting season than
uring the competitive season, whereas diameters remain
nchanged (23). In our study, all measurements were taken
t the same moment in the competitive season in 1995 and
998. Moreover, the difference observed in the group of
yclists examined twice was similar to that observed in the
hole population, eliminating the possibility that the ex-
remely large LV cavities found in certain athletes are due to
specific genetic background (24). Finally, it has been
uggested that heart rate affects M-mode echocardiographic
V measurements (25). However, in our study, heart rate
as not significantly different between the two evaluations.
n the absence of such bias, LV changes may be due to
hanges in the type and intensity of physical training.
owever, to induce a 2-mm difference in LV diameter at
he same moment of the season, training technology must
hange dramatically, and no such change has been reported.
oreover, more intensive and/or prolonged physical train-
ng would have lead to wall thickening (23,26), which was
ot observed in our population. The unexpected and signif-
cant decrease in WT observed with time might also be due
o the increasing problem of drug abuse.
onclusions. In this large homogeneous cohort of highly
rained elite cyclists, marked echocardiographic LV dilation
s frequent and often associated with a low LVEF, which
aises the problem of the differential diagnosis with a dilated
ardiomyopathy. Abnormal increases in WT were less
ommon, always moderate, and usually associated with
avity dilation, eliminating a primary pathologic hypertro-
hy. The unexpected occurrence of cavity dilation and wall
hinning with time raises questions about excessive physical
raining and/or pharmacologic interventions. These results
ight have important implications for myocardial disease
creening in highly trained elite athletes.
ddress for correspondence: Dr. Eric Abergel, Service de Car-
iologie, Hoˆpital Europe´en Georges Pompidou, 20 rue Leblanc,
5908 Paris Ce´dex 15, France. E-mail: eric.abergel@egp.ap-hop-
aris.fr.
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